SULF2 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8IWU5 |
---|---|
Clone Names | 100318244 |
Gene ID | 55959 |
---|---|
Other Names | Extracellular sulfatase Sulf-2, hSulf-2, 316-, SULF2, KIAA1247 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SULF2 |
---|---|
Synonyms | KIAA1247 |
Function | Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity (PubMed:12368295, PubMed:30788513, PubMed:35294879). It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin (PubMed:12368295, PubMed:30788513, PubMed:35294879). |
Cellular Location | Endoplasmic reticulum {ECO:0000250|UniProtKB:Q8VI60}. Golgi apparatus, Golgi stack {ECO:0000250|UniProtKB:Q8VI60}. Cell surface |
Tissue Location | Expressed at highest levels in the ovary, skeletal muscle, stomach, brain, uterus, heart, kidney and placenta |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Heparan sulfate proteoglycans (HSPGs) act as coreceptorsfor numerous heparin-binding growth factors and cytokines and areinvolved in cell signaling. Heparan sulfate 6-O-endosulfatases,such as SULF2, selectively remove 6-O-sulfate groups from heparansulfate. This activity modulates the effects of heparan sulfate byaltering binding sites for signaling molecules (Dai et al., 2005[PubMed 16192265]).
References
Lai, J.P., et al. Hepatology 52(5):1680-1689(2010)Ellinor, P.T., et al. Nat. Genet. 42(3):240-244(2010)Lemjabbar-Alaoui, H., et al. Oncogene 29(5):635-646(2010)Tang, R., et al. J. Biol. Chem. 284(32):21505-21514(2009)Chau, B.N., et al. Cancer Res. 69(4):1368-1374(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.